Bridge to Life Presents New ILTS 2026 Data Showing VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) Expands Use of Marginal Donor Livers and Preserves Mitochondrial Function for Real-Time Viability Assessment

Studies presented as part of "The 2026 International Congress of the International Liver Transplantation Society (ILTS)" in Geneva, Switzerland, May 6-9, 2026 Presentations further support use of HOPE in U.S. and EU for making more organs available for transplantation, reducing registry...